These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling. Frittitta L, Spampinato D, Solini A, Nosadini R, Goldfine ID, Vigneri R, Trischitta V. Diabetes; 1998 Jul; 47(7):1095-100. PubMed ID: 9648833 [Abstract] [Full Text] [Related]
6. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Shao J, Catalano PM, Yamashita H, Ruyter I, Smith S, Youngren J, Friedman JE. Diabetes; 2000 Apr; 49(4):603-10. PubMed ID: 10871198 [Abstract] [Full Text] [Related]
7. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus. Stefanović V, Antić S. Clin Lab; 2004 Apr; 50(5-6):271-8. PubMed ID: 15209435 [Abstract] [Full Text] [Related]
8. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Maddux BA, Goldfine ID. Diabetes; 2000 Jan; 49(1):13-9. PubMed ID: 10615944 [Abstract] [Full Text] [Related]
10. Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine. Grupe A, Alleman J, Goldfine ID, Sadick M, Stewart TA. J Biol Chem; 1995 Sep 22; 270(38):22085-8. PubMed ID: 7673181 [Abstract] [Full Text] [Related]
11. Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity. Belfiore A, Costantino A, Frasca F, Pandini G, Mineo R, Vigneri P, Maddux B, Goldfine ID, Vigneri R. Mol Endocrinol; 1996 Nov 22; 10(11):1318-26. PubMed ID: 8923458 [Abstract] [Full Text] [Related]
12. Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo. Zhou HH, Chin CN, Wu M, Ni W, Quan S, Liu F, Dallas-Yang Q, Ellsworth K, Ho T, Zhang A, Natasha T, Li J, Chapman K, Strohl W, Li C, Wang IM, Berger J, An Z, Zhang BB, Jiang G. Eur J Pharmacol; 2009 Aug 15; 616(1-3):346-52. PubMed ID: 19577557 [Abstract] [Full Text] [Related]
13. The development of insulin resistance with high fat feeding in rats does not involve either decreased insulin receptor tyrosine kinase activity or membrane glycoprotein PC-1. Ozel B, Youngren JF, Kim JK, Goldfine ID, Sung CK, Youn JH. Biochem Mol Med; 1996 Dec 15; 59(2):174-81. PubMed ID: 8986641 [Abstract] [Full Text] [Related]
14. Overexpression of membrane glycoprotein PC-1 can influence insulin action at a post-receptor site. Kumakura S, Maddux BA, Sung CK. J Cell Biochem; 1998 Mar 01; 68(3):366-77. PubMed ID: 9518262 [Abstract] [Full Text] [Related]
16. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, Trischitta V, Vigneri R, Frittitta L. Endocr Rev; 2008 Feb 01; 29(1):62-75. PubMed ID: 18199690 [Abstract] [Full Text] [Related]
17. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, Katagiri H, Fukushima Y, Onishi Y, Ono H, Yazaki Y, Kikuchi M, Oka Y, Asano T. Diabetes; 1999 Jul 01; 48(7):1365-71. PubMed ID: 10389840 [Abstract] [Full Text] [Related]
18. Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-alpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Frittitta L, Youngren JF, Sbraccia P, D'Adamo M, Buongiorno A, Vigneri R, Goldfine ID, Trischitta V. Diabetologia; 1997 Mar 01; 40(3):282-9. PubMed ID: 9084965 [Abstract] [Full Text] [Related]